Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024 - Seite 3

Revenue in EMEA grew by 16.6% c.c., to Euro 144.2 million, with significant achievements recorded in every country, and contributions from both existing and new customers.

Revenue in North America increased by 11.1% c.c. to Euro 84.9 million, thanks to a remarkable performance by the Knee and Shoulder business lines.

Revenue in Asia Pacific rose by 12.6% c.c. to Euro 54.3 million, confirmed a very good pace and a convincing execution in all business lines.

Revenue in Latin America was Euro 5.2 million with a robust increase of 22.3% c.c., driven the gain of market share in existing countries.

 

Revenue by product line

In terms of trend by business lines, the performance was headed by an impressive step up of Knee and Shoulder, which confirmed their excellent progress recorded in 2023. Hip and Spine are progressing with a steady growth trend.

Below we report the 1H 2024 sales break-down by product line:

(Million Euro)	1H 2024	1H 2023	Reported Growth	Constant Currency Growth
Hip	123.7	116.4	6.3%	7.5%
Knee	116.1	98.5	17.9%	18.6%
Extremities*	24.8	17.9	38.9%	39.6%
Spine	24.0	22.4	7.2%	10.0%
TOTAL	288.6	255.1	13.1%	14.3%

* Extremities include Shoulder and Sportsmed revenues